Showing 1,449 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency

Editor's pick
Health GAP (Global Access Project)
8 December 2020
PrEP policies & guidelines

HIV prevention drugs illustrate just how bad pharmaceutical patents are for our health

Editor's pick
NBC News
3 December 2020
Combatting stigma

ViiV Healthcare and Shutterstock Studios unite to tackle outdated perceptions of HIV with ‘HIV in View’ - a first-of-its-kind online HIV photography gallery

Editor's pick
ViiV Healthcare press release
1 December 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
Injectable & long-acting PrEP

ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention

Editor's pick
ViiV press release
17 November 2020
Injectable & long-acting PrEP

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

Editor's pick
POZ
16 November 2020
Clinical trials

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Editor's pick
FDA
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Pharmaceutical industry

US: Gilead's Truvada faces Teva generics assault amid Descovy switching campaign

Editor's pick
FiercePharma
4 October 2020
Pharmaceutical industry

First Generic Truvada Now Available in the United States

Editor's pick
POZ
4 October 2020
Pharmaceutical industry

US: PrEP Costs Must Come Down for Uptake to Increase, Study Says

Editor's pick
American Journal of Managed Care
28 September 2020
PrEP policies & guidelines

UnitedHealthcare spurns Gilead's newer PrEP drug Descovy as Truvada generic looms: report

Editor's pick
FiercePharma
17 August 2020
Government, leadership & policy

MSF applauds South Africa for championing health safeguards at meeting of WTO members

Editor's pick
Reliefweb
4 August 2020
Pharmaceutical industry

Rival drugmakers' joint trial of medicines for COVID includes an experimental HIV drug

Editor's pick
Thomson Reuters Foundation
4 August 2020
Global health initiatives

Covidization of research: what are the risks?

Editor's pick
Nature
3 August 2020
Pharmaceutical industry

Gilead raises 2020 sales forecast to include revenue from COVID-19 drug remdesivir

Editor's pick
Business Today India
31 July 2020
Pharmaceutical industry

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival

Editor's pick
FiercePharma
15 July 2020
New & experimental HIV treatments

FDA spurns CytoDyn's HIV drug because of missing info

Editor's pick
FierceBiotech
14 July 2020
Access to healthcare

NEW DATA: Treat 95% of people living with HIV for just FOUR WEEKS of global HIV drug sales

Editor's pick
ITPC
13 July 2020
Pharmaceutical industry

GSK's ViiV, touting superior long-acting data, can challenge Gilead in HIV prevention: analyst

Editor's pick
FiercePharma
13 July 2020
New & experimental HIV treatments

Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

Editor's pick
Dewpoint press release
13 July 2020